FSTKX
Price
$41.51
Change
+$0.15 (+0.36%)
Updated
Jul 31 closing price
Net Assets
2.81B
RMEBX
Price
$64.44
Change
+$0.03 (+0.05%)
Updated
Jul 31 closing price
Net Assets
118.05B
Interact to see
Advertisement

FSTKX vs RMEBX

FSTKX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
FSTKX vs. RMEBX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSTKX is a Hold and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 118B vs. FSTKX (2.81B). RMEBX pays higher dividends than FSTKX: RMEBX (0.99) vs FSTKX (0.53). FSTKX was incepted earlier than RMEBX: FSTKX (44 years) vs RMEBX (12 years). FSTKX (1.12) and RMEBX (1.07) have similar cost to investors . FSTKX is a more actively managed with annual turnover of: 61.00 vs. RMEBX (30.00). RMEBX has a lower initial minimum investment than FSTKX: RMEBX (250) vs FSTKX (1000000). FSTKX annual gain was more profitable for investors over the last year : 22.74 vs. RMEBX (8.96). RMEBX return over 5 years is better than : 36.13 vs. FSTKX (25.72).
FSTKXRMEBXFSTKX / RMEBX
Total Expense Ratio0.991.0793%
Annual Report Gross Expense Ratio1.121.07105%
Fund Existence44 years12 years-
Gain YTD20.0839.416213%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.81B118B2%
Annual Yield % from dividends0.530.9954%
Returns for 1 year22.748.96254%
Returns for 3 years52.7232.63162%
Returns for 5 years25.7236.1371%
Returns for 10 years78.2090.6486%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEOTX15.100.17
+1.14%
Voya Large Cap Growth Port S2
JRAAX88.86N/A
N/A
Janus Henderson Research A
VLLIX45.39-0.03
-0.07%
Value Line Larger Companies Focus Instl
BHCFX21.68-0.10
-0.46%
Baron Health Care Retail
FBDIX193.96-3.99
-2.02%
Franklin Biotechnology Discovery A